Perforated tissue matrix
US-2024408277-A1 · Dec 12, 2024 · US
Compositions and methods for preventing cardiac arrhythmia
US9084841B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9084841-B2 |
| Application number | US-201514621893-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 13, 2015 |
| Priority date | Feb 18, 2009 |
| Publication date | Jul 21, 2015 |
| Grant date | Jul 21, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are compositions and methods for treating or preventing cardiac arrhythmia in a subject.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating atrial fibrillation in a subject, comprising: providing an extracellular matrix (ECM) composition comprising ECM from a mammalian tissue source comprising acellular basement membrane, said ECM composition further comprising a statin and an exogenously added growth factor comprising transforming growth factor-β (TGF-β), said statin and growth factor being linked to said ECM, wherein, when said ECM composition is administered to damaged my…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9084841B2 cover?
- Disclosed herein are compositions and methods for treating or preventing cardiac arrhythmia in a subject.
- Who is the assignee on this patent?
- Cormatrix Cardiovascular Inc
- What technology area does this patent fall under?
- Primary CPC classification A61L27/3633. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).